| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-05 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.006 |